Neurocrine Biosciences (NBIX) Q3 2026 Earnings

30JulConfirmed
Q4 2025
Q1 2026
Q2 2026
Q3 2026
1.22
1.49
1.77
2.04

Details

Expected EPS
1.649458
Actual EPS
1.39
Surprise EPS
-0.26
Surprise Percent
+15.73%

Description

Neurocrine Biosciences (NBIX) has reported earnings of 1.39 per share for Q3 2026.

0 Comments

Share your thoughts